Intralesional Meglumine Antimoniate for Treatment of Cutaneous Leishmaniasis Patients with Contraindication to Systemic Therapy from Rio de Janeiro (2000 to 2006)

We evaluated the effectiveness and safety of intralesional meglumine antimoniate (MA) in 24 not submitted to previous treatment patients with cutaneous leishmaniasis (CL) and with contraindication to systemic therapy. Each treatment consisted of one to four intralesional applications of MA at 15-day...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Vasconcellos, Érica de Camargo Ferreira e, Pimentel, Maria Inês Fernandes, Schubach, Armando de Oliveira, de Oliveira, Raquel de Vasconcellos Carvalhaes, Azeredo-Coutinho, Rilza Beatriz, Silva, Fátima da Conceição, Salgueiro, Mariza de Matos, Moreira, João Soares, Madeira, Maria de Fátima, Baptista, Cibele, Valete-Rosalino, Cláudia Maria
Materialtyp: Artigo
Språk:Inglês
Publicerad: The American Society of Tropical Medicine and Hygiene 2012
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3414560/
https://ncbi.nlm.nih.gov/pubmed/22855754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2012.11-0612
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk